Home About Login Register Search Archives Announcements

 

Aim and Scope

To provide communication and information exchanging platforms for a broad audience of oncologists, surgeons, medical researchers and professionals working in the field.

Editor-in-Chief

Prof. Dr. Kwong-Kwok Wong
The University of Texas MD Anderson Cancer Center

User
Submit Your Manuscript

Downloads

Manuscript Submission Template

ICMJE Conflict of Interest Form

Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)

Tweets by @AMOR_PiscoMed

Home > Vol 3 (2017) > Office

Predicting response to neoadjuvant chemotherapy in breast cancer

Abstract - 87 PDF - 22
Editorial Office

Abstract


A team of Malaysian researchers has found that neoadjuvant chemotherapy is a reasonable treatment option for localized (hormones negative and HER2 positive) breast cancer and further demonstrating its utility in downstaging primary breast tumor, according to a study published in the recent issue of the journal Advances in Modern Oncology Research (AMOR).


Full Text:

PDF


DOI: http://dx.doi.org/10.18282/amor.v3.is1.217

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Bookmark and Share
                                       

© 2017 by PiscoMed Publishing Pte Ltd